Position in GRAL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,769,372
+$743,103 QoQ
Shares Held
40,565
+3.5% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 374 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $290,484,161 across 21 Diagnostics & Research names. GRAL ranks #12 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
159,181 | $79,806,986 | |
| 2 | DHR |
Danaher Corp /De/
|
201,323 | $38,348,005 | |
| 3 | NTRA |
Natera, Inc.
|
140,931 | $38,255,719 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
28,896 | $36,914,928 | |
| 5 | A |
Agilent Technologies, Inc.
|
176,828 | $23,488,063 | |
| 6 | LH |
Labcorp Holdings Inc.
|
69,568 | $19,479,040 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
28,415 | $14,958,792 | |
| 8 | DGX |
Quest Diagnostics Inc
|
67,692 | $14,347,319 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,769,372 | 40,565 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,026,269 | 39,208 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $854,872 | 9,988 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $966,479 | 16,345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $763,329 | 14,845 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $296,034 | 11,591 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $195,707 | 10,964 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||